These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10892896)

  • 1. Single dose and multiple dose pharmacokinetics of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine, anti-HIV agents, in rats.
    Srinivas NR; Shyu WC
    Eur J Drug Metab Pharmacokinet; 1999; 24(4):329-34. PubMed ID: 10892896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic analysis of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine in dog plasma and urine.
    Campbell DA; Shah VR; Srinivas NR; Shyu WC
    J Pharm Sci; 1996 Aug; 85(8):890-2. PubMed ID: 8863284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cardiotoxicity of nucleoside analogs FddA and FddI in rats.
    Comereski CR; Kelly WA; Davidson TJ; Warner WA; Hopper LD; Oleson FB
    Fundam Appl Toxicol; 1993 Apr; 20(3):360-4. PubMed ID: 8504910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice.
    Ruxrungtham K; Boone E; Ford H; Driscoll JS; Davey RT; Lane HC
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2369-74. PubMed ID: 8891146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.
    Roth JS; McCully CM; Balis FM; Poplack DG; Kelley JA
    Drug Metab Dispos; 1999 Oct; 27(10):1128-32. PubMed ID: 10497138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.
    Hartman NR; Yarchoan R; Pluda JM; Thomas RV; Marczyk KS; Broder S; Johns DG
    Clin Pharmacol Ther; 1990 May; 47(5):647-54. PubMed ID: 2111751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique.
    DeGraw RT; Anderson BD
    Pharm Res; 2004 Feb; 21(2):300-8. PubMed ID: 15032312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic targeting of anti-HIV nucleosides: distribution of 2',3'-dideoxyinosine after intravenous and oral administration of dipalmitoylphosphatidyl prodrug in mice.
    Manouilov KK; Xu ZS; Boudinot FD; Schinazi RF; Chu CK
    Antiviral Res; 1997 May; 34(3):91-9. PubMed ID: 9191016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
    Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG
    Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
    DeGraw RT; Anderson BD
    Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 2',3'-dideoxyadenosine in dogs.
    Wientjes MG; Placke ME; Chang MJ; Page JG; Kluwe WM; Tomaszewski JE
    Invest New Drugs; 1991 May; 9(2):159-68. PubMed ID: 1908444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in mice.
    el Dareer SM; Tillery KF; Kalin JR; Hill DL
    Invest New Drugs; 1989 Jul; 7(2-3):139-46. PubMed ID: 2507472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine (FddA) via a purine 3'-deoxynucleoside.
    Takamatsu S; Maruyama T; Katayama S; Hirose N; Naito M; Izawa K
    J Org Chem; 2001 Nov; 66(22):7469-77. PubMed ID: 11681963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.
    King JR; Nachman S; Yogev R; Hodge J; Aldrovandi G; Damle B; Smith E; Wiznia A; Acosta EP
    Antivir Ther; 2002 Dec; 7(4):267-70. PubMed ID: 12553481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
    Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
    Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat.
    Donzanti BA; Kelley JA; Tomaszewski JE; Roth JS; Tosca P; Placke M; Singer A; Yarrington JT; Driscoll JS
    Fundam Appl Toxicol; 1995 Sep; 27(2):167-76. PubMed ID: 8529811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an effect of azithromycin on the disposition of zidovudine and dideoxyinosine in HIV-infected patients.
    Amsden G; Flaherty J; Luke D
    J Clin Pharmacol; 2001 Feb; 41(2):210-6. PubMed ID: 11210404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.